Covid vaccine mixing: Govt says 'data required' to make recommendation on mixing of jabs
NEW DELHI : The Indian government informed that the National Technical Advisory Group on Immunisation (NTAGI) needs adequate scientific data to make a recommendation on mixing of Covid-19 vaccines.
In the latest development, Central Drugs Standard Control Organization (CDSCO) has granted permission to the Christian Medical College, Vellore to conduct phase-IV study with Covishield and Covaxin to compare immunogenicity of mixed vaccine regimen and to anti for phase-2 clinical trial to evaluate the immunogenicity and safety of Covaxin with BBV154 (Adenoviral Intranasal Covid-19 vaccine).
Minister of State for Health Bharati Pravin Pawar in a written reply to the Rajya Sabha said, “Adequate scientific data is required for NTAGI to make a recommendation on mixing of Covid-19 vaccines, at present this information is not available." She was responding to question on whether the government is considering mixing of Covid-19 vaccines based on heterologous strategies conducted earlier for other diseases, to induce combined antibody and cell-mediated immune response resulting in stronger and long-lasting immunity and if any study has been undertaken in this regard.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|